Tegoprubart Improves Quality of Life vs Tacrolimus After Kidney Transplant

Published Date: 26 Oct 2026

Tegoprubart Improves Quality of Life vs Tacrolimus After Kidney Transplant

Read Full News

Latest News

What MEnD-AKI Revealed About AI Alerts, With Sandra Kane-Gill, PharmD, MS Sandra Kane-Gill, PharmD, MS

In the MEnD-AKI trial, pharmacists reviewed deep learning predictions of AKI risk across 38 hospital service clusters at 8 hospitals.

AI Alerts Did Not Reduce Kidney Events, With Sandra Kane-Gill, PharmD, MS Sandra Kane-Gill, PharmD, MS

In the MEnD-AKI trial, pharmacists reviewed deep learning predictions of AKI risk across 38 hospital service clusters at 8 hospitals.

Why PAD Goes Undetected in Advanced CKD, With Pranav Garimella, MBBS, MPH Pranav Garimella, MBBS, MPH

Calcified vessels may mask PAD on ankle brachial index testing, and Garimella says nephrologists can help catch it earlier.

Sleeve Gastrectomy Improves Heart, Kidney MRI Markers in Youth-Onset T2D Phoom Narongkiatikhun, MD

Phoom Narongkiatikhun, MD, discusses sleeve gastrectomy reducing LV mass, kidney volume, and albuminuria and boosting medullary FSOC in youth-onset T2D.

Tenapanor Lowers Serum Phosphate Regardless of Binder Use in Dialysis

Tenapanor Lowers Serum Phosphate Regardless of Binder Use in Dialysis

Robotics and Organ Preservation in Transplant, With Ari Cohen, MD Ari Cohen, MD, MBA

An Ochsner transplant surgeon discusses 10,000 transplants and how new tools are expanding who can receive an organ.

Todays Updates

Endovascular Therapy Benefit in Distal Vessel Stroke Tied to Severity, Not IVT Status Marco Meglio

A secondary analysis of the DISTAL trial found endovascular therapy's benefit depended more on stroke severity than on prior thrombolysis treatment.

NeurologyLive® Friday 5 — October 23, 2026 Isabella Ciccone, MPH

Take 5 minutes to catch up on NeurologyLive®'s highlights from the week ending October 23, 2026.

Is Pregnancy Riskier for Living Kidney Donors? With Amit X. Garg, MD, PhD Amit X. Garg, MD, PhD

A Canadian cohort found modestly greater preeclampsia risk after donation, though most pregnancies were uncomplicated.

Counseling Kidney Donors on Future Pregnancy, With Amit Garg, MD, PhD Amit X. Garg, MD, PhD

Future pregnancy plans don’t preclude living kidney donation, but candidates should be counseled on gestational hypertension risk.

Sparsentan Lowers Inflammatory, Complement Biomarkers in IgAN

Sparsentan Lowers Inflammatory, Complement Biomarkers in IgAN

Todays Updates

Endovascular Therapy Benefit in Distal Vessel Stroke Tied to Severity, Not IVT Status Marco Meglio

A secondary analysis of the DISTAL trial found endovascular therapy's benefit depended more on stroke severity than on prior thrombolysis treatment.

NeurologyLive® Friday 5 — October 23, 2026 Isabella Ciccone, MPH

Take 5 minutes to catch up on NeurologyLive®'s highlights from the week ending October 23, 2026.

Is Pregnancy Riskier for Living Kidney Donors? With Amit X. Garg, MD, PhD Amit X. Garg, MD, PhD

A Canadian cohort found modestly greater preeclampsia risk after donation, though most pregnancies were uncomplicated.

Counseling Kidney Donors on Future Pregnancy, With Amit Garg, MD, PhD Amit X. Garg, MD, PhD

Future pregnancy plans don’t preclude living kidney donation, but candidates should be counseled on gestational hypertension risk.

Sparsentan Lowers Inflammatory, Complement Biomarkers in IgAN

Sparsentan Lowers Inflammatory, Complement Biomarkers in IgAN

Latest News

In the MEnD-AKI trial, pharmacists reviewed deep learning predictions of AKI risk across 38 hospital service clusters at 8 hospitals.

In the MEnD-AKI trial, pharmacists reviewed deep learning predictions of AKI risk across 38 hospital service clusters at 8 hospitals.

Calcified vessels may mask PAD on ankle brachial index testing, and Garimella says nephrologists can help catch it earlier.

Phoom Narongkiatikhun, MD, discusses sleeve gastrectomy reducing LV mass, kidney volume, and albuminuria and boosting medullary FSOC in youth-onset T2D.

Tenapanor Lowers Serum Phosphate Regardless of Binder Use in Dialysis

An Ochsner transplant surgeon discusses 10,000 transplants and how new tools are expanding who can receive an organ.

News All Time

Inside FIND-CKD: The Data Behind the Trial's 23% Risk Reduction Brendon Neuen, MBBS, PhD, Shikha Wadhwani, MD, MS

Brendan Neuen breaks down the full FIND-CKD primary and secondary endpoint data, subgroup consistency, and safety signals.

Inside FIND-CKD: Can Finerenone Pair With Immunosuppression in GN? Brendon Neuen, MBBS, PhD, Shikha Wadhwani, MD, MS

Brendon Neuen explains why finerenone's mechanism supports combining it with immunosuppressive therapy in glomerulonephritis.

You Don't Need to Be a GN Specialist to Identify Glomerular Disease Earlier George Vasquez-Rios, MD

George Vasquez-Rios, MD, explains the barriers in GN care that ASN's new compendium may address.

Uromodulin Drop Offers Clues to SGLT2 Kidney Protection, With Greco Malijan, MD Greco Malijan, MD

In EMPA-KIDNEY, empagliflozin cut urinary uromodulin 63% without signs of tubular injury, reshaping views on SGLT2 inhibitor mechanisms.

New ASN Compendium Tackles Fragmented GN Care, With Vasquez-Rios, MD George Vasquez-Rios, MD

A new ASN compendium curates scattered GN care guidance into one living resource, says nephrologist George Vasquez-Rios, MD

ASN Kidney Week 2026 Preview: 8 Late-Breakers We’ll Unpack With the Investigators

Preview 8 late-breaking studies and HCPLive's investigator interviews at ASN Kidney Week 2026, spanning IgAN, dialysis, transplantation, and CKD.

Sibeprenlimab Stabilizes eGFR Over 24 Months in IgA Nephropathy: VISIONARY Abigail Brooks, MA

Final VISIONARY data show sibeprenlimab held eGFR steady over 24 months, with a 4.5 mL/min/1.73 m² per year slope advantage and fewer kidney outcome events vs placebo.

Mezagitamab, an anti-CD38 Monoclonal Antibody, Stabilizes eGFR 18 months Off Treatment in IgAN Patrick Campbell

Final 96-week phase 1b data show sustained UPCR reduction and stable eGFR about 1.5 years after the last mezagitamab dose, with no serious adverse events.

Iptacopan Maintains Kidney Benefit Through 48 Months in IgA Nephropathy

Iptacopan Maintains Kidney Benefit Through 48 Months in IgA Nephropathy

Lack of CKD Awareness Limits GLP-1 RA Kidney Protection in Over 9 Million US Adults

Lack of CKD Awareness Limits GLP-1 RA Kidney Protection in Over 9 Million US Adults

Retatrutide Lowers Albuminuria, Glomerular Pressure in Obesity and CKD

Retatrutide Lowers Albuminuria, Glomerular Pressure in Obesity and CKD

Ravulizumab Receives FDA Accelerated Approval for IgA Nephropathy

Ravulizumab Receives FDA Accelerated Approval for IgA Nephropathy

10 Nephrology Headlines You Missed in Q3 2026

10 Nephrology Headlines You Missed in Q3 2026

Personalizing IgA Nephropathy Care Conversations, With Gaia Coppock, MD Gaia Coppock, MD

Why patients with IgA nephropathy want to understand their disease, not just follow instructions.

Mistaken for a UTI: Diagnosing IgA Nephropathy, With Gaia Coppock, MD Gaia Coppock, MD

A survey of patients with IgA nephropathy shows how nonspecific symptoms and long referral waits delay diagnosis by up to two years.

6 Nephrology Headlines You Missed in September 2026

6 Nephrology Headlines You Missed in September 2026

Recommended News For You

tobacco use, the severity of their symptoms, and their desire to give up smoking among cancer survivors.

Microplastics can cause malignant changes in lung cells

According to a study, patients with ovarian cancer who undergo aggressive surgery have a 70% lower chance of dying.

Elder Abuse: Red Flags to Look Out For While Receiving Care.

Healthcare in the Mix in President Biden's Farewell Address

GLP-1 receptor agonists show anti-cancer benefits beyond weight loss

Long Wait Times on the Other Side of the Pond: King Charles' Cancer Diagnosis.

Recommended Articles For You

Case-Based Learning on Adaptive Sequencing of Multimodal Therapy in Rare Solid Malignancies 

A Glimmer of Hope: The Predictive Power of Liquid Biopsy and AI in Palliative Oncology 

Breaking Barriers in Cancer Treatment: The Role of Innovative Oncology Drugs 

AI Classification of Blood-Cell Morphology Variants 

Whats more on Hidoc Dr.

Medical Updates
KOL Videos
Surveys
Events

Daily news to keep you up to date

Gain valuable insights with our in-depth KOL Video discussions

Participate and win cash vouchers

Get updates on the latest events happening around the world
Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

Weight-Based and Fixed-Dose Pembrolizumab Compared in NSCLC

2.

Study Linking Fruits, Veggies to Lung Cancer Raises Eyebrows

3.

Climate change is expected to increase the number of suicide deaths

4.

Vaccine shows promise for pancreatic cancer, study finds

5.

Oncology Care Model’s Net Losses Well Exceed Savings

1.

Surgical Innovation Through Bone Marrow–Reserving Surgical Strategies

2.

Unlocking the Mystery of Leukemia: Exploring New Treatments and Hope for Patients

3.

Integrated Models in Hematology for Specialists

4.

Emerging Frameworks in Oncology in Clinical Decision-Making

5.

Undersanding Alemtuzumab: What You Need To Know About This Multiple Sclerosis Medication

1.

International Conference on Innovations in Critical Care for Oncology and Cardiology

2.

International Conference on Oncology, Cardiology and Critical Care Policy

3.

International Conference on Oncology, Cancer Prevention and Public Health

4.

International Conference on Cancer Nursing and Rehabilitation Strategies

5.

International Conference on Best Practices in Oncology, Cardiology and Critical Care

1.

Iron Deficiency Anemia: Ferric Maltol As a New Treatment Option

2.

Should We Use DARA Up Front As First-Line Therapy in MM?

3.

Lorlatinib in the Management of 1st line ALK+ mNSCLC (CROWN TRIAL Update) - Conclusion

4.

From Relapse to Remission : Chasing the Invisible and Redefining Long-Term Survival in Adult R/R B-Cell ALL

5.

How Platelet Disorders Can Affect the Body

Fastest Growing Medical Platform for Doctors

Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801

Phone :
+1-415-463-3094

Email :
anishagadia@hidoc.co

Quick Links

Drug DatabaseDrug InteractionDiseases Database
KOL VideosKnowledge HubQuizzes
Medical UpdatesEventsAbout Us

© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
Home
Profile
Login
bot